Release Date: 15/12/17 17:43 Summary: Dispatch of Bidder's Statement to SMC Shareholders Price Sensitive: No Download Document 1.39MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%